Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang-Rok Lee

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Chonnam Medical Journal|February 2, 2024
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel StudyDoo Sun Sim, Dae Young Hyun, Young Joon Hong, et al.
Chonnam Medical Journal|February 6, 2018
Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter TrialDoo Sun Sim, Myung Ho Jeong, Young Joon Hong, et al.
Medicine|November 28, 2023
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studySeung-Ah Lee, Soon Jun Hong, Jung-Hoon Sung, et al.
Journal of Korean Medical Science|April 7, 2011
A prediction rule to identify severe cases among adult patients hospitalized with pandemic influenza A (H1N1) 2009Won Sup Oh, Seung-Joon Lee, Chang-Seop Lee, et al.
Clinical Therapeutics|February 10, 2016
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical StudyHan Cheol Lee, Sang-Rok Lee, Kyoo-Rok Han, et al.
Lancet (London, England)|February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trialJeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.
American Heart Journal|April 19, 2024
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Lancet (London, England)|September 3, 2025
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
European Heart Journal|January 6, 2026
Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Yonsei Medical Journal|June 27, 2023
Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI RegistrySang Yoon Lee, Ki Hong Choi, Taek Kyu Park, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Chonnam Medical Journal|February 2, 2024
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel StudyDoo Sun Sim, Dae Young Hyun, Young Joon Hong, et al.
Chonnam Medical Journal|February 6, 2018
Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter TrialDoo Sun Sim, Myung Ho Jeong, Young Joon Hong, et al.
Medicine|November 28, 2023
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studySeung-Ah Lee, Soon Jun Hong, Jung-Hoon Sung, et al.
Journal of Korean Medical Science|April 7, 2011
A prediction rule to identify severe cases among adult patients hospitalized with pandemic influenza A (H1N1) 2009Won Sup Oh, Seung-Joon Lee, Chang-Seop Lee, et al.
Clinical Therapeutics|February 10, 2016
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical StudyHan Cheol Lee, Sang-Rok Lee, Kyoo-Rok Han, et al.
Lancet (London, England)|February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trialJeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.
American Heart Journal|April 19, 2024
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Lancet (London, England)|September 3, 2025
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
European Heart Journal|January 6, 2026
Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Yonsei Medical Journal|June 27, 2023
Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI RegistrySang Yoon Lee, Ki Hong Choi, Taek Kyu Park, et al.
Pageof 15